1. Home
  2. LBRDK vs KYMR Comparison

LBRDK vs KYMR Comparison

Compare LBRDK & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Broadband Corporation Class C

LBRDK

Liberty Broadband Corporation Class C

HOLD

Current Price

$50.95

Market Cap

6.4B

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$85.53

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDK
KYMR
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LBRDK
KYMR
Price
$50.95
$85.53
Analyst Decision
Strong Buy
Analyst Count
0
26
Target Price
N/A
$107.72
AVG Volume (30 Days)
777.5K
565.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,211,000.00
Revenue This Year
N/A
$10.61
Revenue Next Year
$109.28
$8.16
P/E Ratio
$10.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.10
$24.23
52 Week High
$104.00
$103.00

Technical Indicators

Market Signals
Indicator
LBRDK
KYMR
Relative Strength Index (RSI) 48.91 55.74
Support Level $48.17 $77.78
Resistance Level $55.26 $95.90
Average True Range (ATR) 1.83 3.76
MACD 0.15 0.76
Stochastic Oscillator 56.77 72.91

Price Performance

Historical Comparison
LBRDK
KYMR

About LBRDK Liberty Broadband Corporation Class C

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: